LL-37 boosts immunosuppressive function of placenta-derived mesenchymal stromal cells

BACKGROUND: Although promising for graft-versus-host disease (GvHD) treatment, MSC therapy still faces important challenges. For instance, increasing MSC migratory capacity as well as potentializing immune response suppression are of interest. For GvHD management, preventing opportunistic infections...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Stem Cell Res Ther
मुख्य लेखकों: Oliveira-Bravo, Martha, Sangiorgi, Bruno Braga, Schiavinato, Josiane Lilian dos Santos, Carvalho, Juliana Lott, Covas, Dimas Tadeu, Panepucci, Rodrigo Alexandre, Neves, Francisco de Assis Rocha, Franco, Octávio Luiz, Pereira, Rinaldo Wellerson, Saldanha-Araujo, Felipe
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BioMed Central 2016
विषय:
Research
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5203704/
https://ncbi.nlm.nih.gov/pubmed/28038684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-016-0448-3
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन